SCHEMBL6081489

SCHEMBL6081489

Cc1ccc(S(=O)(=O)N2CC2c2ccc(Cl)cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.73
KMT2A Q03164 2/20 0.55
RAB9A P51151 1/20 0.55
USP2 O75604 3/20 0.53
CRHBP P24387 1/20 0.53
CRHR2 Q13324 1/20 0.53
PSEN1 P49768 3/20 0.50
PSEN2 P49810 3/20 0.50
APH1B Q8WW43 3/20 0.50
NCSTN Q92542 3/20 0.50
APH1A Q96BI3 3/20 0.50
PSENEN Q9NZ42 3/20 0.50
HSD11B1 P28845 1/20 0.50
NPSR1 Q6W5P4 1/20 0.49
TAAR1 Q96RJ0 1/20 0.48
GFER P55789 1/20 0.48
MEN1 O00255 1/20 0.48
POLB P06746 1/20 0.48
NCOA1 Q15788 1/20 0.47
NCOA3 Q9Y6Q9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17970867 1.00 ALDH1A1 (0.73) ALDH1A1KMT2ARAB9AUSP2CRHBP
SCHEMBL2600488 0.92 ALDH1A1 (0.64) ALDH1A1KMT2ARAB9ACRHBPCRHR2
SCHEMBL17970865 0.92 ALDH1A1 (0.64) ALDH1A1KMT2ARAB9ACRHBPCRHR2
SCHEMBL29278817 0.85 PSEN1 (0.61) ALDH1A1USP2CRHBPCRHR2PSEN1
SCHEMBL6081660 0.85 TRPA1 (0.58) ALDH1A1KMT2ARAB9ANPSR1POLB
SCHEMBL6081299 0.85 ALDH1A1 (0.55) ALDH1A1KMT2ARAB9ACRHBPCRHR2
SCHEMBL31004054 0.84 ALDH1A1 (0.88) ALDH1A1KMT2ARAB9APSEN1PSEN2
SCHEMBL5252168 0.84 ALDH1A1 (1.00) ALDH1A1KMT2ARAB9APSEN1PSEN2
SCHEMBL17970866 0.84 ALDH1A1 (0.78) ALDH1A1KMT2ARAB9APSEN1PSEN2
SCHEMBL931458 0.84 ALDH1A1 (0.78) ALDH1A1KMT2ARAB9APSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108997215-A A kind of preparation method of 1,2,3,4- tetrahydro isoquinoline derivative 武汉大学 2018-12-14 CN disclosed
US-20160222423-A1 ENZYME-CATALYZED ENANTIOSELECTIVE AZIRIDINATION OF OLEFINS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2016-08-04 US disclosed
US-20160222423-A1 ENZYME-CATALYZED ENANTIOSELECTIVE AZIRIDINATION OF OLEFINS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2016-08-04 US disclosed
US-20160222423-A1 ENZYME-CATALYZED ENANTIOSELECTIVE AZIRIDINATION OF OLEFINS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2016-08-04 US disclosed
CN-105753752-A Chiral vicinal diamine compound and method for preparing same 安徽师范大学 2016-07-13 CN disclosed
CN-104804004-A Preparation method of chiral hexahydropyrroloindole compound UNIV ANHUI NORMAL 2015-07-29 CN disclosed
US-20060030718-A1 Cobalt-based catalysts for the cyclization of alkenes UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2006-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060030718-A1 Cobalt-based catalysts for the cyclization of alkenes PPOX, HCCS, ICOSLG ALDH1A1 3259/4885KMT2A 1748/4885RAB9A 4044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.